Home
/
SELECT MEDICAL HOLDINGS CORP
/
Financials
/
Quarterly
SELECT MEDICAL HOLDINGS CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SELECT MEDICAL HOLDINGS CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$1.27B
Nov 1, 2018
Q3
2018
Sep 30, 2017
$1.08B
Nov 1, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.36B
Oct 30, 2025
Q2
2025
Jun 30, 2025
$1.34B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$1.35B
May 1, 2025
Q3
2025
Sep 30, 2024
$1.27B
Oct 30, 2025
Q2
2025
Jun 30, 2024
$1.28B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$1.32B
May 1, 2025
Q3
2024
Sep 30, 2023
$1.67B
Oct 31, 2024
Q2
2024
Jun 30, 2023
$1.67B
Aug 1, 2024
Q1
2024
Mar 31, 2023
$1.66B
May 2, 2024
Q3
2023
Sep 30, 2022
$1.57B
Nov 2, 2023
Q2
2023
Jun 30, 2022
$1.58B
Aug 3, 2023
Q1
2023
Mar 31, 2022
$1.60B
May 4, 2023
Q3
2022
Sep 30, 2021
$1.53B
Nov 3, 2022
Q2
2022
Jun 30, 2021
$1.56B
Aug 4, 2022
Q1
2022
Mar 31, 2021
$1.55B
May 5, 2022
Q3
2021
Sep 30, 2020
$1.42B
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.23B
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.41B
May 6, 2021
Q3
2020
Sep 30, 2019
$1.39B
Oct 29, 2020
Q2
2020
Jun 30, 2019
$1.36B
Jul 30, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$28.79M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$40.57M
Jul 31, 2025
Q3
2025
Jun 30, 2025
$40.57M
Oct 30, 2025
Q2
2025
Mar 31, 2025
$56.68M
Jul 31, 2025
Q3
2025
Mar 31, 2025
$56.68M
Oct 30, 2025
Q1
2025
Mar 31, 2025
$56.68M
May 1, 2025
Q3
2025
Sep 30, 2024
$55.63M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$77.56M
Jul 31, 2025
Q3
2025
Jun 30, 2024
$77.56M
Oct 30, 2025
Q1
2025
Mar 31, 2024
$96.90M
May 1, 2025
Q2
2025
Mar 31, 2024
$96.90M
Jul 31, 2025
Q3
2025
Mar 31, 2024
$96.90M
Oct 30, 2025
Q3
2024
Sep 30, 2023
$48.18M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$78.24M
Aug 1, 2024
Q3
2024
Jun 30, 2023
$78.24M
Oct 31, 2024
Q2
2024
Mar 31, 2023
$70.81M
Aug 1, 2024
Q3
2024
Mar 31, 2023
$70.81M
Oct 31, 2024
Q1
2024
Mar 31, 2023
$70.81M
May 2, 2024
Q3
2023
Sep 30, 2022
$27.17M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$55.21M
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$72.96M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$86.53M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$112.75M
May 1, 2025
Q3
2025
Sep 30, 2024
$54.90M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$73.86M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$118.47M
May 1, 2025
Q3
2024
Sep 30, 2023
$129.96M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$159.20M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$151.46M
May 2, 2024
Q3
2023
Sep 30, 2022
$91.47M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$120.97M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$103.99M
May 4, 2023
Q3
2022
Sep 30, 2021
$150.26M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$283.97M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$202.01M
May 5, 2022
Q3
2021
Sep 30, 2020
$156.13M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$119.52M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$128.68M
May 6, 2021
Q3
2020
Sep 30, 2019
$122.91M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$124.88M
Jul 30, 2020